It’s all change in Europe’s sterile manufacturing market… or is it?

The last six months has seen some major changes to the sterile manufacturing landscape here in Europe. There have been a number of exits and acquisitions that have no doubt made the market sit up and listen but has anything really changed?At an industry level, the demand for sterile injectable manufacturing capability is evident and industry publications regularly publish indicators of growth… Read More

Symbiosis gains Approval for French Tax Credit

Recently Symbiosis Pharmaceutical Services applied for a CIR (Crédit d’Impôt de Recherche) tax accreditation from the Minister of higher Education and research in France for R&D work on behalf of French companies. Our request was favourably accepted and we are now approved until 2016.The CIR tax accreditation has provided Symbiosis with a strong basis to working with French companies and allows eligible… Read More

Symbiosis reçoit l’agrément pour le CIR

Symbiosis Pharmaceutical Services a fait récemment une demande pour un agrément CIR – Crédit d’Impôt Recherche – auprès du Ministère de l’Enseignement Supérieur et de la Recherche en tant que prestataire pour des travaux R&D. Notre demande a été accueillie favorablement et est accordée au titre des années 2014, 2015, 2016.L’agrément CIR nous donne l’opportunité de travailler avec les entreprises françaises et… Read More

UNICEF Campaign – Massive Success

Last week we sent out a newsletter inviting you all to connect with us via LinkedIn and Twitter and in return we would donate ten Tetanus vaccines per follower to UNICEF. We had many reasons behind this, including : raising our social media profile, we put out a lot of interesting content via our social media networks on a weekly basis and… Read More

Get In Touch